Serum Group

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 72 Experts worldwide ranked by ideXlab platform

Kenji Kusumoto - One of the best experts on this subject based on the ideXlab platform.

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing
    Elsevier, 2019
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Introduction: Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods: We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results: The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions: The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice. Keywords: Platelet lysate, Gelatin hydrogel, Cryopreservation, Lyophilization, Long-term preservation, Wound healin

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing.
    Regenerative therapy, 2018
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Abstract Introduction Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice.

Sharon Claudia Notodihardjo - One of the best experts on this subject based on the ideXlab platform.

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing
    Elsevier, 2019
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Introduction: Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods: We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results: The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions: The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice. Keywords: Platelet lysate, Gelatin hydrogel, Cryopreservation, Lyophilization, Long-term preservation, Wound healin

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing.
    Regenerative therapy, 2018
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Abstract Introduction Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice.

Toshihito Mitsui - One of the best experts on this subject based on the ideXlab platform.

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing
    Elsevier, 2019
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Introduction: Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods: We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results: The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions: The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice. Keywords: Platelet lysate, Gelatin hydrogel, Cryopreservation, Lyophilization, Long-term preservation, Wound healin

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing.
    Regenerative therapy, 2018
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Abstract Introduction Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice.

Yasuhiko Tabata - One of the best experts on this subject based on the ideXlab platform.

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing
    Elsevier, 2019
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Introduction: Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods: We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results: The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions: The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice. Keywords: Platelet lysate, Gelatin hydrogel, Cryopreservation, Lyophilization, Long-term preservation, Wound healin

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing.
    Regenerative therapy, 2018
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Abstract Introduction Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice.

Natsuko Kakudo - One of the best experts on this subject based on the ideXlab platform.

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing
    Elsevier, 2019
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Introduction: Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods: We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results: The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions: The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice. Keywords: Platelet lysate, Gelatin hydrogel, Cryopreservation, Lyophilization, Long-term preservation, Wound healin

  • Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing.
    Regenerative therapy, 2018
    Co-Authors: Sharon Claudia Notodihardjo, Naoki Morimoto, Natsuko Kakudo, Toshihito Mitsui, Yasuhiko Tabata, Kenji Kusumoto
    Abstract:

    Abstract Introduction Human platelet lysate (hPL) part of the growth factor cocktail derived from human platelets, which has been applied as a cell growth supplement. The production process is easier in comparison to platelet-rich plasma; thus, hPL is now considered for use in wound healing therapy. However, methods for preserving hPL for more than several months that maintain its bioactivity must be considered, especially for chronic wound treatment. The present study compared the effects of preservation for 9 months using a refrigerator or deep freezer. Methods We investigated three preservation conditions. In the C-hPL Group, hPL was stored at −80 °C in a deep freezer for 9 months; in the CL-hPL Group, hPL was cryopreserved for 9 months at −80 °C in a deep freezer then lyophilized; in the L-hPL Group, lyophilized hPL was refrigerated at 4 °C for 9 months. The quantity and quality of growth factors in these three Groups were measured by an ELISA and in fibroblast cell cultures. Then, gelatin hydrogel discs were impregnated with hPL and its effects with regard to the promotion of wound healing in mice were evaluated by histologic examinations. Results The PDGF-BB concentration in C-hPL, CL-hPL and L-hPL was 18,363 ± 370 pg/ml, 11,325 ± 171 pg/ml, and 12,307 ± 348 pg/ml, respectively; the VEGF concentration was 655 ± 23 pg/ml, 454 ± 27 pg/ml, and 499 ± 23 pg/ml, respectively; and the TGF-β1 concentration was 97,363 ± 5418 pg/ml, 73,198 ± 2442 pg/ml, and 78,034 ± 3885 pg/ml, respectively. In cell culture medium, fibroblast cell cultures were better supported in the hPL Groups than in the fetal bovine Serum Group. In the histologic examination of the wound healing process, no differences were observed among the three preserved hPL Groups with regard to epithelialization, or granulation tissue or capillary formation. The wounds in all Groups had almost healed by day 14. Conclusions The stability of growth factors contained in lyophilized hPL is maintained at 4 °C for up to 9 months. This was a versatile preservation method that can be applied in clinical practice.